看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | -0.1x - -0.1x | -0.1x |
| Selected Fwd P/E Multiple | -0.1x - -0.1x | -0.1x |
| Fair Value | C$0.013 - C$0.014 | C$0.014 |
| Upside | 30.6% - 44.4% | 37.5% |
| Benchmarks | - | Full Ticker |
| Decibel Cannabis Company Inc. | - | TSXV:DB |
| Street Capital Inc. | - | CNSX:STRC.X |
| Avicanna Inc. | - | TSX:AVCN |
| ZYUS Life Sciences Corporation | - | TSXV:ZYUS |
| Devonian Health Group Inc. | - | TSXV:GSD |
| RAMM Pharma Corp. | - | CNSX:RAMM |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| DB | STRC.X | AVCN | ZYUS | GSD | RAMM | |||
| TSXV:DB | CNSX:STRC.X | TSX:AVCN | TSXV:ZYUS | TSXV:GSD | CNSX:RAMM | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | ||
| 3Y CAGR | 98.3% | NM- | NM- | NM- | NM- | NM- | ||
| Latest Twelve Months | 1081.9% | 59.7% | 65.2% | 16.2% | -24.6% | -53.7% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -10.6% | -632.1% | -681.7% | -8822.3% | -152.0% | -257.7% | ||
| Prior Fiscal Year | -1.8% | -174.9% | -52.1% | -12134.2% | -196.1% | -152.4% | ||
| Latest Fiscal Year | 14.7% | -75.8% | -14.2% | -7028.1% | -6.9% | -380.1% | ||
| Latest Twelve Months | 12.4% | -50.8% | -10.0% | -7157.2% | -13.8% | -334.2% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 35.5x | -7.8x | -12.7x | -4.8x | 8.8x | -0.1x | ||
| Price / LTM Sales | 0.5x | 3.2x | 1.3x | 110.3x | 0.7x | 0.3x | ||
| LTM P/E Ratio | 4.2x | -6.4x | -13.1x | -1.5x | -5.2x | -0.1x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -13.1x | -5.2x | 4.2x | |||||
| Historical LTM P/E Ratio | -7.8x | -3.7x | -0.1x | |||||
| Selected P/E Multiple | -0.1x | -0.1x | -0.1x | |||||
| (x) LTM Net Income | (14) | (14) | (14) | |||||
| (=) Equity Value | 1 | 1 | 2 | |||||
| (/) Shares Outstanding | 119.4 | 119.4 | 119.4 | |||||
| Implied Value Range | 0.01 | 0.01 | 0.01 | |||||
| FX Rate: CAD/CAD | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 0.01 | 0.01 | 0.01 | 0.01 | ||||
| Upside / (Downside) | 18.7% | 25.0% | 31.2% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | DB | STRC.X | AVCN | ZYUS | GSD | RAMM | |
| Value of Common Equity | 49 | 1 | 33 | 53 | 22 | 1 | |
| (/) Shares Outstanding | 576.7 | 280.4 | 117.8 | 78.0 | 148.2 | 119.4 | |
| Implied Stock Price | 0.09 | 0.01 | 0.28 | 0.68 | 0.15 | 0.01 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 0.09 | 0.01 | 0.28 | 0.68 | 0.15 | 0.01 | |
| Trading Currency | CAD | CAD | CAD | CAD | CAD | CAD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |